A detailed history of Eagle Claw Capital Managment, LLC transactions in Sanofi stock. As of the latest transaction made, Eagle Claw Capital Managment, LLC holds 41,375 shares of SNY stock, worth $2.01 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
41,375
Previous 40,475 2.22%
Holding current value
$2.01 Million
Previous $2.01 Million 0.1%
% of portfolio
0.37%
Previous 0.43%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$45.75 - $52.48 $41,175 - $47,232
900 Added 2.22%
41,375 $2.01 Million
Q4 2023

Feb 14, 2024

BUY
$43.13 - $54.79 $309,457 - $393,118
7,175 Added 21.55%
40,475 $2.01 Million
Q3 2023

Nov 07, 2023

BUY
$50.95 - $55.2 $28,022 - $30,360
550 Added 1.68%
33,300 $1.79 Million
Q2 2023

Aug 09, 2023

BUY
$50.45 - $57.18 $65,585 - $74,334
1,300 Added 4.13%
32,750 $1.77 Million
Q1 2023

May 04, 2023

BUY
$45.86 - $54.45 $1.44 Million - $1.71 Million
31,450 New
31,450 $1.71 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $122B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Eagle Claw Capital Managment, LLC Portfolio

Follow Eagle Claw Capital Managment, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Claw Capital Managment, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Claw Capital Managment, LLC with notifications on news.